Regulus Therapeutics暴涨,诺华拟斥资至多17亿美元收购该公司

老虎资讯综合
30 Apr

周三,美国生物技术公司Regulus Therapeutics盘初暴涨超140%,。消息面上,诺华宣布,达成收购Regulus Therapeutics的协议,交易包括8亿美元预付款,达到未来监管里程碑后可能额外支付至多9亿美元。该交易预计将于今年下半年完成。

Regulus Therapeutics致力于开发microRNA疗法,专注于治疗常染色体显性多囊肾病(ADPKD)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10